chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two adverse events. 1) at time of shot there was a needle retraction malfunction, so when doser began giving the dose, some squirted out. Baby subsequently had to be redosed with a second shot so may have received a higher than standard dose  2) patient had angioedema/anaphylaxis at 545 pm while eating dinner. Had to go to the Emergency room and get epinephrine/steroids/famotidine/Zyrtec. No history of previous food allergies. Possible this was related to food as it was during dinner but was the same day as the vaccine.
Fever, headache, aches in all body, insomnia,  tremors, redness and  swelling in area of the vaccine with  high ache during  3 days.  At fourth day the aches start healing  but there is a rash in area of the vaccine
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 87-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021 at 9:27 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.
Ill-scratchy throat, stuffy head, tired, cough settled in chest. Green phlegm and called MD. Zithromax ordered and completed. 12/17/02 states twk 2nd antibiotic and new bronchitis subsiding. Some SOB and cough yet hx of bronchitis.
Information has been received from a physician concerning a 79 year old male who on 20-MAY-2006 was vaccinated with a first dose of Pneumovax 23 (lot# 650302/1039F), subcutaneous in the upper posterior left arm. There was no concomitant medication. On 30-MAY-2006 the patient experienced swelling, redness, induration and cellulitis. The patient was treated with ice. It was reported that "patient's arm is slightly worse than yesterday." There were no relevant diagnostic tests or laboratory data. At the time of the report, the patient was considered to be not recovered. Follow up information has been received from the physician concerning the male patient with hypertension and high cholesterol who was vaccinated with his first dose of Pneumovax 23 on 30-MAY-2006, on 20-MAY-2006 as previously reported. The physician stated that on 01-JUN-2006, not 30-MAY-2006 as originally reported, the patient developed cellulitis-like reaction from the site of the injection distally 10 cm. Symptoms included redness, swelling, increased secondary warmth, induration, and mild tenderness. The patient's outcome was unknown. Additional information is not expected.
72hrs after receiving Pfizer Covid-19 vaccine the pt started experiencing left submandibular pain and swelling. 24hrs after symptoms started the pt was seen by his PCP. The PCP exam revealed mild left mandibular swelling, tenderness upon palpation, no erythema of the buccal mucosa/gums, no warmth or erythema of the overlying skin, a small firm mass palpated near the submandibular gland.  Out patient Neck ultrasound obtained that revealed enlarged lymph nodes, CBC done in office that was within normal limits. Pt dx with submandibular lymphendopathy and advised to continue otc Advil as needed for the pain.
1 wk bed after FLUZONE HIGH DOSE, got violently ill, jerking and shaking out of control, freezing feet turned blue to ankles. Alone. Couldn't call at time. Put body in warm water to warm up - Dr on call. Neuropathy feet, hands and body. Feet hot and hands since flu shot. Wrong diagnosis finally. Neuropathy from flu shot.
COVID infection/tested positive for COVID 19; COVID infection/tested positive for COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Lot number: ER2613), on 09Apr2021 as dose 2, single (Lot number: ER8729) and on 03Sep2021 as dose 3 (booster), single (Lot number: FA6780) at the age of 61 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 02Apr2022 as dose 4 (booster), single (Lot number: 002m21A) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "Interchange of vaccine products" (unspecified if ongoing), notes: Vaccine brand other: Moderna,. Concomitant medication(s) included: HYDROXYCHLOROQUIN; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; OMEPRAZOL; LISINOPRIL. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID infection/tested positive for COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (13Apr2022) Negative, notes: I tested negative for infection on 13Apr2022; (15Apr2022) Positive, notes: On 15Apr2022 I tested positive for COVID 19; (26Apr2022) Positive, notes: still remain positive for COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: Patient received Paxlovid on 08Apr2022 for a COVID infection. Patient took the full, five day course. Her symptoms resolved and she tested negative for infection on 13Apr2022. On 14Apr2022 her symptoms began to return. On 15Apr2022 she tested positive for COVID 19. Today was 26Apr2022 and she still remain positive for COVID-19. Her symptoms were mild, however, she cannot seem to clear the infection post-Paxlovid. No known allergies were present.  No follow-up attempts are possible. No further information is expected.
Approximately 7 hours after vaccination, had uncontrollable shaking (cold), dizzy, weak, fever.
Could not walk, could not seat, fever, sticking out her tongue, the back of her legs get heat up. Treated fever with infant fever-reducer. The fever came down but she still could not walk or seat up straight.
still tired; 2nd shot: fri woke in horrible pain all joints and muscles; 2nd shot: fri woke in horrible pain all joints and muscles; Barley walk; chills; beginning of fever; brain fog; This is a spontaneous report from a contactable consumer (patient). A 48-year-old-female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP6955 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 01Apr2021 at 04:30 PM (age at vaccination: 48 years), as dose 2, single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included tachycardia, iron deficiency anemia, and known allergies: Omitted. Concomitant medications included motropolol, acetylsalicylic acid (BABY ASPRIN), curcuma longa (TURMERIC), magnesium, and vita. Past drug included amoxicillin and had known allergies: amoxicillin. Historical vaccine included first dose of BNT162B2 (PFIZ-ER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6199 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 11Mar2021 at 01:30 PM, as dose 1, single dose for COVID-19 immunization at hospital and had breast pain right breast for days. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 02Apr2021, the patient had 2nd shot: fri woke in horrible pain all joints and muscles. Barley walk. By 2:30, chills and beginning of fever. By 5pm, she had 105.5 fever while on Motrin. Fever bt 102.8 and 103.8 through the night while alternating tylonal and Motrin every 3 hours. Saturday no fever, brain fog, exhaustion. Sunday still tired and muscle weakness. Monday still not feeling really gut- no energy. Now it was Friday, day 8 and still feel off with throat/ breath. She could breathe deeply, but slight cough and tightness at base of throat. The patient did not receive any treatment for the events. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
MMRV was given to a child older than 12 yrs of age. Family called and left message to call back so we can inform them of the incident.
Client received their first dose of Pfizer's Covid-19 Vaccine at roughly 14:27. Client completed their monitoring period, and was released with no reaction. Client returned at 15:15 complaining of tightness in the throat. Client was breathing clearly and speaking with no difficulty. One dose of Benadryl 25mg was administered at 15:17 and the client was monitored for 15 minutes. Client reports feeling much better at 15:32. Client was advised to carry Benadryl at home. Client was educated on further signs of an allergic reaction, treatment with Benadryl, and when to go to the ER.
HYPOTENSION 1/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
had an allergic reaction to the second shot / their are negative side effects; put on meds that burnt her throat; put on meds that / left her unable to eat much for over a week; This case was reported by a consumer via media and described the occurrence of allergic reaction in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced allergic reaction, burn local and unable to eat. On an unknown date, the outcome of the allergic reaction and burn local were unknown and the outcome of the unable to eat was recovered/resolved.   It was unknown if the reporter considered the allergic reaction, burn local and unable to eat to be related to Meningococcal B vaccine.  Additional details were reported as follows: This case was reported by patient's parent. The age at vaccination was not reported. The patient had an allergic reaction to the second dose of vaccine. The patient ended up being put on medicines that burnt her throat and was unable to eat much for over a week. The reporter sated that even though this experience was rare but it still happened. The reporter stated that there were some negative side effects of vaccinations that also needs to be talked about. No other information was reported. Notes : No information about allergic medicines was reported and it was drug class hence medicines which were used to treat allergic reactions were only mentioned in additional details and was not captured as suspect in Argus for events throat burn and unable to eat much.
Pt has a lump in her lymph node 3/4 inch by 1/2 inch under her arm where the IMZ was administered. The morning after the IMZ, 2-15-20, she saw the lump and it was painful. As of today, 2-20-20 the patient said there is no pain in the lump. She cannot say if the lump is decreasing from 2-15-20
Patient received J&J vaccine in April 2021. Was admitted to the hospital 8/7-8/18, for Covid-19 pneumonia. She required transfer to the ICU but not intubation. Was treated with dexamethasone, remdesivir and tocilizumab.
A week after received my first dose, I started to experience pain in both hands and swelling in the knuckles.  I just kept ignoring it. June 8, 2021, I showed it to my doctors. She ran a rheumatoid arthritis panel on June 21, 2022. She sent me to a rheumatologist specialist on June 22, 2022. That rheumatologist diagnosed me with rheumatoid arthritis.
Light headedness and slight nausea; not severe; Light headedness and slight nausea; not severe; Uncomfortable; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  An 86-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 01Mar2021 (Lot number: EN6202) at the age of 86 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "surgery on her ankle on her leg" (unspecified if ongoing); "cancerous condition she had in a breast" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious), NAUSEA (non-serious) all with onset 01Mar2021, outcome "recovered" (Mar2021) and all described as "Light headedness and slight nausea; not severe"; DISCOMFORT (non-serious) with onset 01Mar2021, outcome "recovered" (Mar2021), described as "Uncomfortable". Therapeutic measures were not taken as a result of dizziness, nausea, discomfort.  Additional information: The patient stated she was taking a lot of medication. She had high blood pressure, she was taking an anti-hormonal drug for a cancerous condition she had in a breast and she was taking a blood thinner. She was also taking a multivitamin. The patient started to experience the events about 4 hours into or maybe 6 hours or more after vaccination because it was almost evening. The patient did not have treatment for the events but said she ate something and that seemed to help. The patient was due for the second dose on 22Mar2021.  No follow-up attempts are possible. No further information is expected.
After 1st dose - 1 episode pallor and clamminess, After 2nd dose - 2 episodes pallor and clamminess symptoms self - resolved.
Patient developed numbness and tingling into her left arm after receiving the COVID Vaccine. After several minutes, patient states is just felt like her left arm was heavy. Patient states this has occurred before and that she carries and Epi pen.  CAT called but patient declined to go to ED stating that she will be working here until 3:00 today and felt comfortable calling for assistance if anything changes.
Red raised 2 inch in diameter blotchy spot.  Extremely painful and sensitive even to clothing.   Could not raise arm above shoulder level.  Mild tiredness. Better today which is 2 days after injection.
Child had vaccines on 12/16/13, developed fever following day bwt. 102 degrees-104 degrees F. Was seen in ER 12/20/13 and dx with URI and discharged with MOTRIN and phenylephrine 0.125 drops. Fever cont. 2 more days. Doctor feels the fever was d/t respiratory illness rather than vaccine.
Bad headache, right side of face pain, vision issues, chest pain, blocked right ear, went to er, did tests "all ok". 5 days later and still feel awful everyday. Minor to moderate headaches, low grade fever, minor chest pain, heart racing, fatigue, brain fog.
02/14/2003: Hives on both legs and slightly itching-per patient; 02/17/2003: Itching all over-per patient; 02/23/2003: Hives everywhere; went to ER-per patient; 02/28/2003: Saw allergist.
patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event; patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event; Initial information received on 15-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 8 months old female patient who was inadvertently administered a dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL VACCINE) for Prophylactic vaccination.  On 10-Feb-2023, the patient received a 0.5 ml dose 1 of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (strength, expiry date, formulation: unknown, lot UJ682AAA) via intramuscular route in the left thigh as immunization.  On 10-Feb-2023 the patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event (poor quality product administered) (product storage error).  No lab data was reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event, patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event).  At time of reporting, the outcome was Unknown for the event patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event and was Unknown for the event patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Short electric shock-like sensation that travels from the left foot (above the heel) to the upper thigh. This happened twice on the afternoon after the vaccine, and once the following morning (today).
Please understand that I have no idea as to whether patient's illness is a result of the vaccine but I feel that I should at least report the experience.  Patient was given the shot at 9 on Friday morning, July 27 in Dr. office.  Sunday evening, July 29, she developed a sore pea sized swelling under the skin where her jaw is attached.  She woke us at 3:30 am on Monday with a completely swollen side of her face-- she was given an x-ray and CAT scan and oral antibiotics at the Hospital emergency room and released with an appointment with a local ENT at mid-day.  He placed patient in Hospital for one round of IV antibotics, gave her a blood test and wanted to see her the following day.  The tests came back with a slightly elevated WBC,SEGS, and LYMPH count.  After seeing that her face continued to swell, he referred us to Dr. at Hospital.  Patient was hospitalized under his care from Tuesday through Friday on IV antibiotics and had an additional contrast CAT which revealed no stones, tumors, but did show an enlarged parotid gland and jugular lymph node.  The swelling is down to just a bit puffy now and Patient was released on oral antibiotics.  There is no known reason for this situation at this time.  8/20/2007 MR received for DOS 7/31/2007-8/3/2007 for c/o severe swelling on the L side of face with increasing pain. PE (+) for significant L parotid gland erythema, warmth, and induration.  some increased lymph node in the jugulodigatric area. (+) Trismus. Txd with abx with improvement. Final DX: Sialadenitis.
I felt bad after both vaccines. After receiving the second dose, I started to feel bad about one hour later. It lasted for several days like 3-4 days, but it was something to be expected. Over the next few months, I felt like something was off and I did not feel like myself. I told my doctor about this, and he decided to run some tests. He did lab work and it showed severely low vitamin D, ferritin, and iron. They were borderline. He treated me on oral medication for vitamin D and iron. I was unable to tolerate the iron so we moved to an infusion. I have been feeling a little better since the infusion but I have to go back to get my levels re-checked.
severe cough; couch ridden; pulled back muscle; down for the count; headache; extreme fatigue; swollen feet; left shoulder where she received the vaccine has been hurting; This spontaneous case was reported by an other and describes the occurrence of COUGH (severe cough), BEDRIDDEN (couch ridden), MUSCLE STRAIN (pulled back muscle), ILLNESS (down for the count) and PERIPHERAL SWELLING (swollen feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Endometrial cancer. Concomitant products included LENVATINIB MESILATE (LENVIMA) from 25-Mar-2021 to an unknown date and PEMBROLIZUMAB (KEYTRUDA) for Endometrial cancer.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced VACCINATION SITE PAIN (left shoulder where she received the vaccine has been hurting). On 08-Jul-2021, the patient experienced PERIPHERAL SWELLING (swollen feet). On an unknown date, the patient experienced COUGH (severe cough), BEDRIDDEN (couch ridden), MUSCLE STRAIN (pulled back muscle), ILLNESS (down for the count), HEADACHE (headache) and FATIGUE (extreme fatigue). The patient was treated with NAPROXEN SODIUM (ALEVE) for Vaccination site pain, at an unspecified dose and frequency and GABAPENTIN for Vaccination site pain, at an unspecified dose and frequency. At the time of the report, COUGH (severe cough), BEDRIDDEN (couch ridden), MUSCLE STRAIN (pulled back muscle), ILLNESS (down for the count), PERIPHERAL SWELLING (swollen feet), HEADACHE (headache), FATIGUE (extreme fatigue) and VACCINATION SITE PAIN (left shoulder where she received the vaccine has been hurting) outcome was unknown.            The patient has increased and new lung nodules and new lesions on her liver per PT scan. Patient was awaiting x-ray results to confirm that the arm was not broken.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: The additional information document received with Lab information is added On 03-Jun-2021: EISAI confirms document receipt, ESAI case ID number provided On 04-Jun-2021: NNI On 03-Aug-2021: New events added.
No adverse events reported. 3rd dose of Moderna accidentally administered as booster before Moderna was approved for use as a booster.
2 month-old male with abdominal pain and irritability after Rotavirus vaccine. Seen at Emergency Room. KUB negative.
9APR t102, swelling @ inject site & leg; given APAP; D/V w/irritability; t100.7 R; tiredness; 17APR pt turned blue/mottling over complete body; to ER; started screaming then color changed to pink w/some mottling; 27APR some diarrhea;